Frequent Evolution of Copy Number Alterations in CLL Following First-Line Treatment With FC(R) Is Enriched With TP53 Alterations: Results From the CLL8 Trial
Leukemia - United Kingdom
doi 10.1038/leu.2016.317
Full Text
Open PDFAbstract
Available in full text
Date
November 2, 2016
Authors
Publisher
Springer Science and Business Media LLC